- Home
- ALMU vs MRVI Comparison
ALMU vs MRVI Comparison
Compare ALMU & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMU
- MRVI
- Stock Information
- Founded
- ALMU 2019
- MRVI 2014
- Country
- ALMU United States
- MRVI United States
- Employees
- ALMU N/A
- MRVI N/A
- Industry
- ALMU Semiconductors
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- ALMU Technology
- MRVI Health Care
- Exchange
- ALMU Nasdaq
- MRVI Nasdaq
- Market Cap
- ALMU 301.7M
- MRVI 312.4M
- IPO Year
- ALMU N/A
- MRVI 2020
- Fundamental
- Price
- ALMU $13.33
- MRVI $2.08
- Analyst Decision
- ALMU
- MRVI Hold
- Analyst Count
- ALMU 0
- MRVI 10
- Target Price
- ALMU N/A
- MRVI $6.84
- AVG Volume (30 Days)
- ALMU 424.4K
- MRVI 1.5M
- Earning Date
- ALMU 08-07-2025
- MRVI 08-06-2025
- Dividend Yield
- ALMU N/A
- MRVI N/A
- EPS Growth
- ALMU N/A
- MRVI N/A
- EPS
- ALMU N/A
- MRVI N/A
- Revenue
- ALMU $3,627,488.00
- MRVI $241,856,000.00
- Revenue This Year
- ALMU N/A
- MRVI N/A
- Revenue Next Year
- ALMU N/A
- MRVI $10.73
- P/E Ratio
- ALMU N/A
- MRVI N/A
- Revenue Growth
- ALMU 335.67
- MRVI N/A
- 52 Week Low
- ALMU $2.50
- MRVI $1.67
- 52 Week High
- ALMU $19.50
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- ALMU N/A
- MRVI 46.40
- Support Level
- ALMU N/A
- MRVI $2.00
- Resistance Level
- ALMU N/A
- MRVI $2.44
- Average True Range (ATR)
- ALMU 0.00
- MRVI 0.15
- MACD
- ALMU 0.00
- MRVI -0.03
- Stochastic Oscillator
- ALMU 0.00
- MRVI 20.45
About ALMU Aeluma Inc. Common Stock
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.